The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the US FDA has granted accelerated approval of TALVEY™.
[Johnson & Johnson]
Home Newsletters Cell Therapy News US FDA Approves TALVEY™ (Talquetamab-Tgvs), a First-in-Class Bispecific Therapy for the Treatment...
